{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:42:33Z","timestamp":1793922153916,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13555-023-00958-4","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T10:01:56Z","timestamp":1686909716000},"page":"1617-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Kynurenine Pathway in Psoriasis\u2014a Promising Link?"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1414-4569","authenticated-orcid":false,"given":"A.","family":"Stepaniuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"9","key":"958_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/metabo12090833","volume":"12","author":"J Nowowiejska","year":"2022","unstructured":"Nowowiejska J, Baran A, Flisiak I. Fatty acid-binding proteins in psoriasis-a review. Metabolites. 2022;12(9):833.","journal-title":"Metabolites"},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"643449","DOI":"10.3389\/fmicb.2021.643449","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, He J, Li J, et al. Microbiome and metabolome analyses reveal novel interplay between the skin microbiota and plasma metabolites in psoriasis. Front Microbiol. 2021;12:643449.","journal-title":"Front Microbiol"},{"issue":"1","key":"958_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","volume":"90","author":"MF de Oliveira","year":"2015","unstructured":"de Oliveira MF, de Oliveira Rocha B, Duarte GV. Psoriasis: classical and emerging comorbidities. Bras Dermatol. 2015;90(1):9\u201320.","journal-title":"Bras Dermatol"},{"issue":"3","key":"958_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases Part I. Epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"958_CR5","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/jcm9093004","volume":"9","author":"J Wild","year":"2020","unstructured":"Wild J, Hobohm L, M\u00fcnzel TK. Psoriasis and its impact on in-hospital outcome in patients hospitalized with acute kidney injury. J Clin Med. 2020;9(9):3004.","journal-title":"J Clin Med"},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4103\/0378-6323.72462","volume":"76","author":"N Nisa","year":"2010","unstructured":"Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:662\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"958_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","volume":"36","author":"P Gisondi","year":"2018","unstructured":"Gisondi P, Fostini AC, Foss\u00e0 I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21\u20138.","journal-title":"Clin Dermatol"},{"issue":"6","key":"958_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022;36(6):797\u2013806.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"958_CR9","first-page":"188","volume":"32","author":"MA Gupta","year":"1993","unstructured":"Gupta MA, Schork NJ, Gupta DK, Kirby S, Ellis CN. Suicidal ideation in psoriasis International. J Dermatol. 1993;32:188\u201390.","journal-title":"J Dermatol"},{"issue":"11","key":"958_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2340\/actadv.v101.565","volume":"101","author":"S H\u00f6lsken","year":"2021","unstructured":"H\u00f6lsken S, Krefting F, Sondermann W. Common fundamentals of psoriasis and depression. Acta Derm Venereol. 2021;101(11):565.","journal-title":"Acta Derm Venereol"},{"key":"958_CR11","first-page":"273","volume":"107","author":"J Nowowiejska","year":"2020","unstructured":"Nowowiejska J, Baran A, Flisiak I. Zaburzenia snu w \u0142uszczycy. Dermatol Rev\/Przegl Dermatol. 2020;107:273\u201380.","journal-title":"Dermatol Rev\/Przegl Dermatol"},{"key":"958_CR12","doi-asserted-by":"publisher","first-page":"917751","DOI":"10.3389\/fnmol.2022.917751","volume":"15","author":"J Nowowiejska","year":"2022","unstructured":"Nowowiejska J, Baran A, Flisiak I. Psoriasis and neurodegenerative diseases\u2014a review. Front Mol Neurosci. 2022;15:917751.","journal-title":"Front Mol Neurosci."},{"issue":"7","key":"958_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","volume":"15","author":"I Davis","year":"2015","unstructured":"Davis I, Liu A. What is the tryptophan kynurenine pathway and why is it important to neuro-therapy? Expert Rev Neurother. 2015;15(7):719\u201321.","journal-title":"Expert Rev Neurother"},{"key":"958_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173243","volume":"209","author":"BD Alvarez","year":"2021","unstructured":"Alvarez BD, Morales CA, Amodeo DA. Impact of specific serotonin receptor modulation on behavioral flexibility. Pharmacol Biochem Behav. 2021;209: 173243.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"958_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/molecules27010273","volume":"27","author":"TD Hughes","year":"2022","unstructured":"Hughes TD, G\u00fcner OF, Iradukunda EC, Phillips RS, Bowen JP. The kynurenine pathway and kynurenine 3-monooxygenase inhibitors. Molecules. 2022;27(1):273.","journal-title":"Molecules."},{"issue":"7","key":"958_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom12070998","volume":"12","author":"K Hestad","year":"2022","unstructured":"Hestad K, Alexander J, Rootwelt H, Aaseth JO. The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules. 2022;12(7):998.","journal-title":"Biomolecules"},{"issue":"1","key":"958_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25(1):131\u201347.","journal-title":"Mol Psychiatry"},{"issue":"10\u201311","key":"958_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1159\/000519811","volume":"52","author":"HN Wee","year":"2021","unstructured":"Wee HN, Liu JJ, Ching J, Kovalik JP, Lim SC. The kynurenine pathway in acute kidney injury and chronic kidney disease. J Am J Nephrol. 2021;52(10\u201311):771\u201387.","journal-title":"J Am J Nephrol"},{"issue":"6","key":"958_CR19","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11136-021-02991-2","volume":"31","author":"B Schuster","year":"2022","unstructured":"Schuster B, Peifer C, Ziehfreund S, Tizek L, Biedermann T, Zink A, Schielein MC. Hap-piness and depression in psoriasis: a cross-sectional study in Germany. Qual Life Res. 2022;31(6):1761\u201373.","journal-title":"Qual Life Res"},{"key":"958_CR20","doi-asserted-by":"crossref","unstructured":"Wang X, Li Y, Wu L. et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother 2021;137:111065","DOI":"10.1016\/j.biopha.2020.111065"},{"issue":"4","key":"958_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.det.2005.05.014","volume":"23","author":"RG Fried","year":"2005","unstructured":"Fried RG, Gupta MA, Gupta AK. Depression and skin disease. Dermatol Clin. 2005;23(4):657\u201364.","journal-title":"Dermatol Clin"},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neubiorev.2018.01.009","volume":"87","author":"KM Sanders","year":"2018","unstructured":"Sanders KM, Akiyama T. The vicious cycle of itch and anxiety. Neurosci Biobehav Rev. 2018;87:17\u201326.","journal-title":"Neurosci Biobehav Rev"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","volume":"101","author":"ER Paul","year":"2022","unstructured":"Paul ER, Schwieler L, Erhardt S, et al. Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav Immun. 2022;101:136\u201345.","journal-title":"Brain Behav Immun."},{"issue":"11","key":"958_CR24","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.3390\/ijms22115903","volume":"22","author":"F Z\u00e1dor","year":"2021","unstructured":"Z\u00e1dor F, Joca S, Nagy-Gr\u00f3cz G, et al. Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression. Int J Mol Sci. 2021;22(11):5903.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"958_CR25","first-page":"2997","volume":"236","author":"L Sforzini","year":"2019","unstructured":"Sforzini L, Nettis MA, Mondelli V, Pariante CM. Inflammation in cancer and depression: a starring role for the kynurenine pathway. Psychopharmacology. 2019;236(10):2997\u20133011.","journal-title":"Psychopharmacology"},{"key":"958_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","volume":"56","author":"J Dahl","year":"2015","unstructured":"Dahl J, Andreassen OA, Verkerk R, et al. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers. Psychoneuroendocrinology. 2015;56:12\u201322.","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"958_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the United Kingdom. Br J Dermatol. 2010;163(3):586\u201392.","journal-title":"Br J Dermatol"},{"key":"958_CR28","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Parra E, Daud\u00e9n E, Carrascosa JM. et al. En representaci\u00f3n del Grupo de Trabajo en Inflamaci\u00f3n Sist\u00e9mica en Psoriasis Kidney Disease and Psoriasis. A New Comorbidity? Actas Dermosifiliogr 2016;107(10):823\u201329","DOI":"10.1016\/j.adengl.2016.05.025"},{"issue":"1","key":"958_CR29","first-page":"123","volume":"27","author":"NP Singh","year":"2005","unstructured":"Singh NP, Prakash A, Kubba S, et al. Psoriatic nephropathy\u2013does an entity exist? Ren Fai. 2005;27(1):123\u20137.","journal-title":"Ren Fai"},{"key":"958_CR30","doi-asserted-by":"crossref","unstructured":"Pires AS, Gupta S, Barton SA. et al. Temporal profile of kynurenine pathway metabolites in a rodent model of autosomal recessive polycystic kidney disease. Int J Tryptophan Res. 2022; 10.11786469221126063","DOI":"10.1177\/11786469221126063"},{"key":"958_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12885-020-06956-5","volume":"20","author":"S Wang","year":"2020","unstructured":"Wang S, Wu J, Shen H, Wang J. The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis. BMC Cancer. 2020;20:471.","journal-title":"BMC Cancer"},{"key":"958_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880201","volume":"13","author":"J Bu","year":"2022","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol. 2022;13: 880201.","journal-title":"Front Immunol"},{"issue":"3","key":"958_CR33","volume":"11","author":"HA Alidrisi","year":"2019","unstructured":"Alidrisi HA, Hamdi KA, Mansour AA. Is there any association between psoriasis and Hashimoto\u2019s thyroiditis? Cureus. 2019;11(3): e4269.","journal-title":"Cureus"},{"key":"958_CR34","doi-asserted-by":"crossref","unstructured":"De Francesco MA, Caruso A. The gut microbiome in psoriasis and Crohn\u2019s Disease: is its per-turbation a common denominator for their pathogenesis? Vaccines (Basel) 2022 5;10(2):244.","DOI":"10.3390\/vaccines10020244"},{"issue":"12","key":"958_CR35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","volume":"154","author":"Y Fu","year":"2018","unstructured":"Fu Y, Lee C, Chi C. Association of psoriasis with inflammatory Bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(12):1417\u201323.","journal-title":"JAMA Dermatol"},{"key":"958_CR36","doi-asserted-by":"crossref","unstructured":"Chen L, Bao C, Wu Y. et al. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflamm 2021;18:135.","DOI":"10.1186\/s12974-021-02175-2"},{"key":"958_CR37","doi-asserted-by":"crossref","unstructured":"Dudzi\u0144ska E, Szymona K, Kloc R. et al. Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease. Therap Adv Gastroenterol. 2019; 12: 1756284819881304","DOI":"10.1177\/1756284819881304"},{"issue":"6","key":"958_CR38","first-page":"1830","volume":"137","author":"JL Harden","year":"2016","unstructured":"Harden JL, Lewis SM, Lish S, et al. The tryptophan metabolism enzyme, l-kynureninase, is a novel inflammatory factor in psoriasis and other inflammatory diseases J Allergy. Clin Immunol. 2016;137(6):1830\u201340.","journal-title":"Clin Immunol"},{"issue":"11","key":"958_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11883-021-00963-y","volume":"23","author":"B Weber","year":"2021","unstructured":"Weber B, Merola JF, Husni ME, Di Carli M, Berger JS, Garshick MS. Psoriasis and cardiovascular disease: novel mechanisms and evolving therapeutics. Curr Atheroscler Rep. 2021;23(11):67.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"958_CR40","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","volume":"37","author":"W Masson","year":"2020","unstructured":"Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther. 2020;37(5):2017\u201333.","journal-title":"Adv Ther"},{"issue":"2","key":"958_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","volume":"78","author":"MT Wan","year":"2018","unstructured":"Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: a prospective population-based cohort study. J Am Acad Dermatol. 2018;78(2):315-322.e1.","journal-title":"J Am Acad Dermatol"},{"key":"958_CR42","doi-asserted-by":"crossref","unstructured":"Dubreuil M, Rho YH, Man A. et al. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study Rheumatology (Oxford) 2014;53(2):346\u201352.","DOI":"10.1093\/rheumatology\/ket343"},{"issue":"4","key":"958_CR43","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-4632.2006.02502.x","volume":"45","author":"K Al-Mazeedi","year":"2006","unstructured":"Al-Mazeedi K, El-Shazly M, Al-Ajmi HS. Impact of psoriasis on quality of life in Kuwait. Int J Dermatol. 2006;45(4):418\u201324.","journal-title":"Int J Dermatol"},{"key":"958_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768560","author":"R G\u00e1sp\u00e1r","year":"2022","unstructured":"G\u00e1sp\u00e1r R, Halmi D, Demj\u00e1n V, Berkecz R, Pipicz M, Csont T. Kynurenine pathway metabolites as potential clinical biomarkers in coronary artery disease. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2021.768560.","journal-title":"Front Immunol"},{"issue":"16","key":"958_CR45","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s00018-017-2504-2","volume":"74","author":"P Song","year":"2017","unstructured":"Song P, Ramprasath T, Wang H, Zou M. Abnormal Kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci. 2017;74(16):2899\u2013916.","journal-title":"Cell Mol Life Sci"},{"key":"958_CR46","doi-asserted-by":"publisher","first-page":"117864692210966","DOI":"10.1177\/11786469221096643","volume":"15","author":"M Ala","year":"2022","unstructured":"Ala M, Eftekhar SP. The footprint of kynurenine pathway in cardiovascular diseases. Int J Tryptophan Res. 2022;15:11786469221096644.","journal-title":"Int J Tryptophan Res"},{"key":"958_CR47","doi-asserted-by":"crossref","unstructured":"Pedersen ER, Tuseth N, Eussen SJPM. et al Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Bio 2015;35(2):455\u201362.","DOI":"10.1161\/ATVBAHA.114.304674"},{"key":"958_CR48","doi-asserted-by":"crossref","unstructured":"Clement CC, D\u2019Alessandro A, Thangaswamy S. et al. 3-Hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. Nat Commun. 2021;2:4447.","DOI":"10.1038\/s41467-021-24785-3"},{"key":"958_CR49","doi-asserted-by":"crossref","unstructured":"Fujii K, Yamamoto Y, Mizutani Y, Saito K, Seishima M. Indoleamine 2,3-dioxygenase 2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation. Int J Mol Sci. 2020;21(15):5515.","DOI":"10.3390\/ijms21155515"},{"issue":"3","key":"958_CR50","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/ijms22031104","volume":"22","author":"M Szelest","year":"2021","unstructured":"Szelest M, Walczak K, Plech T. A new insight into the potential role of tryptophan-derived AhR ligands in skin physiological and pathological processes. Int J Mol Sci. 2021;22(3):1104.","journal-title":"Int J Mol Sci"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00958-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00958-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00958-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T09:14:36Z","timestamp":1690190076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00958-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00958-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}